• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    伦

    伦敦大学学院眼科研究所

    UCL Institute of Ophthalmology
    ucl.ac.uk
    2,251论文总数
    10.2万引用总数

    The institute conducts research and post-graduate teaching in the area of ophthalmology (the anatomy, physiology and diseases of the eye).The institute has a staff of around 200, including around 45 principal investigators, and cooperates closely with Moorfields Eye Hospital, which it is located adjacent to and with which it is a partner in the National Institute for Health Research (NIHR) Biomedical Research Centre for Ophthalmology. Together with Moorfields Eye Hospital, the institute is the oldest and largest centre for ophthalmic treatment, teaching and research in Europe.

    论文量&引用量时间轴

    机构学者

    论文(2251)

    年份
    起
    –
    止
    排序
    1Comparing Community-Based Monitoring to Hospital-Based Care of Patients with Quiescent Age-Related Macular Degeneration: a Qualitative Study of Patient and Practitioner Perspectives on Acceptability and Access
    Sofia Vougioukalou, Simon M Read, Judit Katalin Csontos,Aled Jones, Alijazy Jaber, Anitta Sharma,Konstantinos Balaskas

    Objectives This process evaluation explores patient and healthcare professional acceptability of community-based monitoring versus hospital-based care for patients with quiescent neovascular age-related macular degeneration (QnAMD).Design Qualitative process evaluation was conducted as part of a randomised controlled trial.Setting Six hospitals and six community-based practices.Participants 25 patients and 16 healthcare professionals (ophthalmologists and optometrists). This approach helped differentiate between common issues and those specific to community-based monitoring.Intervention The Quality-Assured Follow-Up of QnAMD by non-medical practitioners trial aimed to examine whether non-medical practitioners follow-up patients with QnAMD in the community in a safe and clinically and cost-effective way. The process evaluation aimed to examine whether the intervention was acceptable by patients and professionals. The process evaluation was based on interviews which contained open-ended questions focused on patient experience and confidence in community-based care, issues concerning the practicalities of the organisation and management of the clinic, and resources including IT and digital equipment. The theory of acceptability framework was used to interpret the findings.Results Patients reported positively on the experience of receiving QnAMD services in the community and highlighted staff professionalism and clear communication. Key themes were the proximity of care provision for patients, IT interoperability and the real-world costs of running the service. Some patients randomised to the hospital showed preference for the intervention to take place in the hospital, mediated mainly by prior experience of hospital care and travel distance. The location of the clinic and transport routes affected the experience of attending appointments, with strong preference expressed for proximity to one’s home. Inaccessibility due to non-modifiable internal building structures in the community and parking in hospital eye services was reported by a small proportion of patients. Healthcare professionals reported positively about their ability to deliver QnAMD services in community settings but raised concerns about the compatibility of technological infrastructure that facilitates the sharing of optical coherence tomography image and video files. Some optometrists were also concerned about the financial sustainability of the intervention after the end of the trial due to the costs involved in the administration of QnAMD follow-up care.Conclusions The delivery of QnAMD services in the community by non-medical personnel was broadly accepted by both patients and practitioners. This implies that non-medical practitioners can follow up patients with QnAMD in the community in a safe way. Further research would be needed to establish whether similar results would be obtained during routine practice outside a research project and whether the long-term follow-up for QnAMD would be financially sustainable for independent as well as chain community optometry practices.Trial registration number NCT03893474.

    2026BMJ open(2026)引用:2
    引用
    AI阅读
    加入学术空间
    2Polygenic Risk Scores for Glaucoma: Impact on Diagnosis and Disease Course
    Antonia Kolovos,Tin Aung,Anthony P Khawaja,Janey L Wiggs,Jamie E Craig

    Large-scale genomic studies have uncovered significant polygenic architecture of the adult-onset glaucomas, enabling the creation of polygenic risk scores (PRS). These scores show promise in improving early case detection and predicting disease trajectory, particularly when integrated with clinical parameters, signaling a new frontier for personalised glaucoma risk assessment. As accredited PRS tools enter clinical practice, their safe and equitable implementation is essential. In this review, we synthesize the evidence base for PRS in glaucoma and described the current landscape for clinical implementation. We cover the 'Who, What, When and Where' of PRS testing for glaucoma, highlighting the clinical relevance and limitations of this precision tool.

    2026Progress in retinal and eye research(2026)引用:1
    引用
    AI阅读
    加入学术空间
    3A Predictive Atlas of Disease Onset from Retinal Fundus Photographs: a Modelling Study Using Data from Population-Based Cohorts
    Thore Buergel, Lukas Loock,Jakob Steinfeldt, Noel Kronenberg, Laura Hoffmann, Steffen Emil Künzel, Julius Upmeier Zu Belzen, Lucas Arnoldt,Anthony P Khawaja,Robert Luben, Paul J Foster, Claudia Langenberg,

    BACKGROUND:Early detection of individuals at high risk of disease onset is crucial for health-care systems to cope with changing demographics and an ever-increasing patient population. Images of the retinal fundus are a non-invasive, low-cost examination routinely collected and potentially scalable beyond ophthalmology. Previous work showed the potential of retinal images for risk assessment for some diseases, but it remains unclear whether this potential extends to a broader range of human diseases. We aimed to systematically assess the extent to which retinal fundus photographs can predict incident disease onset across the human phenome, and to benchmark their added value beyond readily available patient characteristics. METHODS:In this modelling study using data from population-based cohorts, we extended a retinal foundation model (RETFound) to systematically explore the predictive potential of retinal images as a screening strategy for disease onset across 752 incident diseases in 61 256 individuals (33 285 [54%] females and 27 971 [46%] males; median age 58 years [IQR 50-63]) from the UK Biobank cohort. Participants had retinal images collected at baseline (Dec 7, 2009, to July 21, 2010) and were linked to routinely collected hospital and death records in the UK. External validation was performed in 7248 individuals (median age 67 years [IQR 62-73]) from the EPIC-Norfolk Eye Study. Predictive improvements were investigated by extracting image attributions from risk models and performing genome-wide association studies. FINDINGS:We showed improved discriminative performance compared with readily available patient characteristics for 306 (41%) of the 752 investigated disease endpoints, including 280 outside of ophthalmology. Retinal information did not improve the prediction for the onset of cardiovascular diseases compared with established primary prevention scores. Predictive improvements were attributable to retinal vascularisation patterns and less obvious features, such as eye colour or lens morphology. Genetic findings highlighted commonalities between eye-derived risk estimates and complex disorders: across 84 retinal risk phenotypes, we identified 1385 genome-wide statistically significant variant associations across 178 loci, including a low-frequency missense variant in IMPA1 (rs204781; minor allele frequency 2·0%) associated with decreased risk estimates across 48 diseases, with the strongest association observed for iron deficiency anaemia (β=-0·16; p<7·2 × 10-16). INTERPRETATION:We present one of the first comprehensive evaluations of predictive information derived from retinal fundus photographs, illustrating the potential and limitations of readily accessible and low-cost retinal images for risk assessment across common and rare diseases. Our findings show the potential of retinal images to complement screening strategies more widely, but also demonstrate the need for rigorous benchmarking and disease-agnostic efforts to design cost-efficient screening strategies to improve population health. FUNDING:Charité - Universitätsmedizin Berlin.

    2026The Lancet Digital health(2026)引用:1
    引用
    AI阅读
    加入学术空间
    4O6 the UK Platform for Nucleic Acid Therapies – Target Selection Guidelines
    Ella F Whittle, Kylie-Ann Montgomery, Catherine Ryan,Emma Clement, Nour Elkhateeb, Manju A Kurian, Jacqui van der Spuy, Stephan J Sanders, Ana Lisa Tavares,Jenny C Taylor,Hannah Titheradge, Nick Lench,
    2026Oral Abstracts(2026)
    引用
    AI阅读
    加入学术空间
    5A Commentary on the Updated Research Priorities in Ophthalmology: Implications and Future Directions
    Rupert R A Bourne,Malik Moledina,Augusto Azuara-Blanco,George M Saleh, James Self,Sobha Sivaprasad,Srilakshmi M Sharma, Andrew Ross, Rose M Gilbert, Maram E A Abdalla Elsayed, Won Young Moon, Manjo Doug,
    2026Eye (London, England)(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 2251 篇论文

    合作机构(100)

    摩尔菲尔德眼科医院合作论文 241
    Moorfields Eye Hospital NHS Foundation Trust合作论文 97
    卢旺天主教大学合作论文 86
    伦敦大学学院合作论文 76
    国王大学合作论文 59
    牛津大学合作论文 59
    剑桥大学合作论文 59
    伦敦大学学院大奥蒙德街儿童健康研究所合作论文 41
    帝国理工学院合作论文 38
    悉尼大学合作论文 37

    机构统计